Polyspecific Antibodies in Lymphoproliferative T-cell Disorders

Clinical trial NCT06495723 · RECRUITING

Trial details

NCT number: NCT06495723
Sponsor: Xenothera SAS
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Peripheral T Cells Lymphoma (PTCL)

Start date: 2024-07-09
Primary completion: 2026-07-31
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.